Pfizer Vaccines Works on the COVID-19 Variant Found in the India

Pfizer has confirmed this new by announcing that their vaccine shows high efficacy towards the COVIS-19 variant found in the India. The variant found in India is very deadly has created a havoc in India by surging in the number of cases daily. India touched the maximum number of cases by any country which was more than 400 Thousand per day.

Sources has also confirmed that the Pfizer vaccine is also effective children aged above 12, and can be stored safely for a month in a cold storage which temperature ranges between 2-8 degree Celsius. If it secures major regulatory relaxations, such as indemnity, or protection from compensation claims in the event of bad events, the American pharma giant is in talks with the government to fast-track approval and roll out five crore doses between July and October.

Covishield, Covaxin, and Sputnik V, the three vaccines currently licensed for use in India, have not been given such protection. Pfizer has insisted on it, and other countries that use the medicine, notably the United States and several European countries, have agreed. Pfizer has shared all the important efficacy data collected from different countries and by WHO. The data obtained are from the UK Public Health England, which reported that the, Pfizer vaccine is 87.9 % efficient towards the B.1.617.2 variant which was reported in India.